key: cord-0748007-08n1h92a
authors: Tang, Zhi-hang; Chen, Qi; Wang, Xia; Su, Nan; Xia, Zhengyuan; Wang, Yong; Ma, Wu-hua
title: A systematic review and meta-analysis of the safety and efficacy of remifentanil and dexmedetomidine for awake fiberoptic endoscope intubation
date: 2021-04-09
journal: Medicine (Baltimore)
DOI: 10.1097/md.0000000000025324
sha: ca714d5f801dd1620acb983ddd2f4914eb39543b
doc_id: 748007
cord_uid: 08n1h92a

BACKGROUND: Awake fiberoptic endoscope intubation (AFOI) is the primary strategy for managing anticipated difficult airways. Adequate sedation, most commonly being achieved with remifentanil and dexmedetomidine, is integral to this procedure. This meta-analysis aimed to compare the safety and efficacy of these 2 sedatives. METHODS: We conducted electronic searches in Embase, Web of Science, PubMed, Google Scholar, Medline, Springer, and Web of Science with no language restrictions. Studies comparing safety and efficacy between the sole use of remifentanil and dexmedetomidine among patients who underwent AFOI were included. Eight randomized controlled trials, comprising 412 patients, met the inclusion criteria. The primary outcomes were first attempt intubation success rate and incidence of hypoxia. The secondary outcomes were the Ramsay Sedation Scale score at intubation, memory recall of endoscopy, and unstable hemodynamic parameters during intubation. RESULTS: Dexmedetomidine significantly reduced the incidence of hypoxemia during AFOI (risk ratio: 2.47; 95% confidence [CI]: 1.32–4.64]) compared with remifentanil; however, the first intubation success rates were equivalent (risk ratio: 1.12; 95% CI: 0.87–1.46]. No significant differences between the 2 sedatives were found for the Ramsay Sedation Scale score at intubation (mean difference: −0.14; 95% CI: −0.66–0.38) or unstable hemodynamic parameters during intubation (risk ratio: 0.83; 95% CI: 0.59–1.17). Dexmedetomidine reduced memory recall of endoscopy (risk ratio: 1.39; 95% CI: 1.13–1.72). CONCLUSIONS: While both remifentanil and dexmedetomidine are effective for AFOI and well-tolerated, dexmedetomidine may be more effective in reducing the incidence of hypoxemia and memory recall of endoscopy. PROSPERP REGISTRATION NUMBER: CRD42020169612.

The awake fiberoptic endoscope intubation (AFOI) technique is the gold standard for the management of patients with predicted difficult airways, especially prior to general anesthesia induc-tion. [1] Nevertheless, the improper application of AFOI can lead to unstable hemodynamics, patient discomfort, and treatment failure; thus, the success of this technique is highly dependent on operator proficiency and a safe sedation scheme. [2] Controlled sedation and analgesia are integral to AFOI, as deep sedation can cause respiratory depression, while shallow anesthesia may result in a rough cough and extreme discomfort. [3] The ideal sedation outcome is to keep the patient quiet with their eyes closed under spontaneous breathing, maintain low sensitivity to nausea and vomiting, and allowing for them to be awakened if necessary. [2, 3] Safety and comfort are the main concerns in the rational use of sedative agents.

The most commonly used sedative agents in operating theaters include benzodiazepines, ketamine, propofol, sevoflurane, remifentanil (REM), and dexmedetomidine (DEX). [2] [3] [4] [5] [6] [7] In non-difficult airway cases, such as selective bronchoscopy, a combination of 2 sedatives can been used to meet procedural needs, [8] but the combination of these drugs during AFOI can result in severe respiratory depression. For safety purposes, the agents chosen for sedation should be short-acting, easily titratable, and have minimal suppression of spontaneous ventilation. [9] Different sedative agents have been shown to have their own advantages and disadvantages, and this has been the focus of a number of prior studies. For instance, several randomized controlled trials (RCTs), [10, [12] [13] [14] case report, [11] and systematic reviews [15, 16] have demonstrated that DEX is superior to midazolam, fentanyl, sufentanil, and propofol when used during AFOI. While previous studies have compared DEX with REM for AFOI, the results have been inconclusive. [17] [18] [19] [20] [21] [22] [23] [24] Thus, we undertook this systematic review and meta-analysis to investigate whether AFOI with DEX would lead to better safety and efficacy when compared with REM.

This meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) Statement guidelines. [25] The protocol of this systematic review was registered with the International Prospective Register of Systematic Reviews (CRD42020169612). Ethical approval was unnecessary as the study protocol consists only of a systematic review and did not involve private patient data.

The literature search was conducted by 2 independent reviewers. In the case of disagreements on study eligibility, the opinion of a third reviewer was obtained. A total of 7 electronic databases (Embase, PubMed, Google Scholar, Medline, Springer, and Web of Science) were searched up to April 20, 2020 with combinations of the following keywords "remifentanil," "dexmedetomidine," "awake intubation," "awake fiberoptic intubation," and "intubation." The search strategy was limited to RCTs conducted on human participants. The including studies were limited to those published in English.

Studies were included if they were 1. RCTs and 2. compared REM and DEX in adult patients undergoing AFOI.

We excluded RCTs comparing other sedatives, local infiltration anesthesia, or thyrocricocentesis. Case reports, review articles, and animal experiments were also excluded.

The methodological quality of each included study was evaluated by 2 independent reviewers; a third reviewer was consulted if disagreements arose. The results of the trial selection process are presented in the PRISMA flowchart (Fig. 1 ).

The Cochrane Collaboration Risk of Bias Tool was used to evaluate the quality of each RCT in terms of selection, performance, detection, attrition, and reporting bias (Fig. 2) . Two authors assessed the RCTs independently and assigned quality scores after reaching a consensus. A third author was consulted when an agreement could not be reached. RCT quality scores were not a factor for trial exclusion.

Data were retrieved independently by 2 reviewers, and subsequently cross-checked. Differences in opinions were resolved by consensus through discussion and consultation with a third reviewer. Extracted data included author names, publication year, number of patients in each group, intubation type, and details of local anesthetic, REM, and DEX usage (Table 1) .

Some studies (e.g., conference abstracts) met our selection criteria but did not report sufficient data. For instance, some of these studies did not present their outcome data as mean and standard deviation or standard error of the mean and 95% confidence interval (CI); in these cases, we sent e-mails to request the original data from the corresponding authors. If a reply was not received, the mean was considered to be equivalent to the median, and the standard deviation was approximated to be the interquartile range divided by 1.35 or the range divided by 4. Hypoxia was defined as a pulse oximetry saturation <90%, and unstable hemodynamic parameters included hypertension, hypotension, tachycardia, and bradycardia. 

The primary outcomes were the success rate of intubation on the first attempt, and the incidence of hypoxia during intubation. Secondary outcomes included the Ramsay Sedation Scale (RSS) score, unstable hemodynamic parameters during intubation, and memory recall of endoscopy.

Revman 5.3 software (Oxford, UK), provided by the Cochrane Collaboration, was used for all statistical analyses. Each continuous outcome was expressed as a mean difference (SD with 95% CI). The relative risk (with 95% CI) was determined for dichotomous data. The level of heterogeneity was determined via the x 2 test P value and the I 2 value. A fixed effects model was performed in cases of data heterogeneity (P > .1 or I 2 < 50%), and a random effects model was performed in cases of data homogeneity (P < .1 or I 2 > 50%). Publication bias was assessed using the Egger test, with P > .05 indicating no statistically significant publication bias. Sensitivity analysis was also utilized to evaluate the stability of article results.

The literature search identified a total of 235 potentially relevant studies, with 8 qualifying RCTs (comprising 412 patients) meeting our inclusion criteria (Fig. 1) . [17] [18] [19] [20] [21] [22] [23] [24] All 8 RCTs compared REM with DEX during AFOI. 

Four studies did not have a high risk of bias for any of the evaluated criteria, while the other 4 studies had almost elements with unclear risk of bias due to abstract only (Fig. 2 ).

Five studies measured the success rate of intubation on the first attempt (n = 208). [17] [18] [19] [20] [21] 24] Although 2 studies reported that REM improved the first intubation attempt success rate, the results of the meta-analysis indicated that there was no significant difference between REM and DEX (95% CI: 0.87-1.46; I 2 = 74%; P = .38). However, there was a large degree of heterogeneity (Fig. 3) . The Egger test did not show obvious evidence of publication bias (P = .093).

The incidence of hypoxia during intubation was reported in 6 studies (n = 298). [17] [18] [19] [20] [21] 24] DEX was associated with a lower incidence of hypoxia during AFOI (95% CI: 1.32-4.64; I 2 = 0%; P = .005) (Fig. 4) . The Egger test for publication bias (P = .215) and sensitivity analysis did not significantly alter these results.

Four studies assessed the level of sedation using the RSS score during intubation (n = 228). [17] [18] [19] [20] RSS scores were not significantly associated with either the use of DEX or REM (95% CI: À0.66 to 0.38; I 2 = 70%; P = .60) (Fig. 5) . The Egger test showed evidence of publication bias (P = .008). 

Five RCTs (n = 218) investigated the incidence of unstable hemodynamic parameters (hypertension, hypotension, tachycardia, and bradycardia) during AFOI. [18, 19, 21, 22] DEX did not reduce the incidence of unstable hemodynamic parameters (95% CI: 0.59-1.17; I 2 = 0%; P = .29) (Fig. 6) . The Egger test for publication bias (P = .120) and sensitivity analysis did not significantly alter the summarized results.

Postoperative recall of the endoscopy procedure was assessed with various methods in the included studies. Four studies (n = 228) utilized a similar evaluation for memory recall of the endoscopy procedure, and were included in the meta-analysis. [17] [18] [19] [20] DEX was associated with a lower postoperative recall of endoscopy compared to REM (95% CI: 1.13-1.72; I 2 = 27%; P = .002) (Fig. 7) . The Egger test for publication bias (P = .352) and sensitivity analysis did not significantly alter the summarized results.

The present meta-analysis was the first to evaluate the safety and efficacy of DEX vs REM when used as the sole sedative agent during AFOI. After analyzing the combined results of 8 RCTs, we found that DEX was associated with a lower incidence of hypoxemia and memory recall of endoscopy compared to REM. The success rate of first intubation was high for both drugs, and no significant difference was observed.

While the AFOI technique has a long track record of success and has been continuously refined over the past decade, the choice of sedative remains a matter of debate. This issue has been especially pertinent during the coronavirus disease pandemic, which has put anesthesiologists at a high risk of nosocomial infection. Thus, it has become increasingly important to reduce aerosol generation during AFOI. This may be achieved by optimizing the intubation procedure to reduce the number of required intubation attempts, and shorten the duration of intubation to improve patient cooperation. Potential measures need to be urgently evaluated and incorporated into detailed intubation plans for the treatment of patients with difficult airway. [26] Although the AFOI technique can be performed safely without the use of sedatives, [27, 28] they are still recommended to reduce anxiety and promote airway tolerance. [9] Nevertheless, it is not easy to achieve a balance between providing an adequate level of sedation for intubation, and reducing the risk of adverse effects. For instance, the co-administration of sedative agents can often result in over-sedation. The use of DEX or REM as the sole sedative agent, however, has been associated with low risks of airway obstruction and over-sedation, as well as high levels of patient satisfaction. [29] REM is a selective m-receptor agonist with a rapid onset and offset of effect. It is a commonly used opioid that can suppress coughing and cardiovascular responses caused by tracheal manipulation. [30, 31] Xu et al compared DEX and REM for sedation during AFOI using a Shikani optical stylet, and reported that the proportion of patients with coughing after intubation in the DEX group was twice that in the REM group. This was www.md-journal.com explained by the greater analgesic effect of REM, which resulted in a better tolerance of the tracheal tube. [19] However, no significant difference in the success rate of intubation on the first attempt was found between the REM and DEX groups in the present meta-analysis. A successful intubation requires that the patient be well sedated, and yet still be able to be aroused and cooperate under instruction. [32] The ability of both REM and DEX to provide an adequate level of sedation at the point of intubation could have accounted for the equivalent first-attempt intubation success rates. DEX is a highly selective a2-adrenergic agonist with intrinsic sedative, anxiolytic, and sympatholytic effects. [33] [34] [35] While it has a rapid onset and equally rapid redistribution half-life with quick recovery, it only has modest efficacy as an analgesic. A number of case reports have indicated that DEX has little effect on respiration; while respiratory depression during the administration of DEX may be observed, it usually only occurs with the use of very large initial bolus doses (1.0 and 2.0 mg/kg intravenously over 2 minutes), [36] or in patients with obesity. Our meta-analysis showed that REM was associated with a higher incidence of hypoxia during AFOI. REM-induced hypoxia is dose-related, and is mainly reflected by a decrease in respiratory rate and minute ventilation. The termination of REM infusion is associated with a quick and spontaneous recovery. [37] A previous study reported that REM sedation administered via target controlled infusion resulted in a lower incidence of apnea and respiratory depression compared with manual administration,. [38] [39] [40] Although the adverse effects of REM on the respiratory system can be easily managed in most cases, it should be used with caution if airway obstruction is already evident before sedation. [41] Excessive anxiety and airway manipulation triggers a mass release of catecholamines via sympathetic stimulation. This leads to an elevation in blood pressure, heartrate, and arrhythmia in patients with risk factors such as hypertension and coronary disease, and increases the risk of myocardial ischemia and infarction. [42, 43] In the present study, we found no evidence to support the superiority of either DEX or REM in terms of hemodynamic stability. While the administration of REM can lead to hypotension and bradycardia, [30, 31] its potent analgesic properties also reduce stimulation by the endoscopy and intubation procedures. The administration of DEX is mainly associated with hypertension, hypotension, and bradycardia caused by vasoconstriction [44] ; nevertheless, with sufficient topical anesthesia and proper sedation, the hemodynamic change during AFOI can be reduced to a minimum. The hemodynamic sensitivity to DEX and REM increases with age and varies according to the patient's preoperative condition.

To the best of our knowledge, there is no standard assessment for patient satisfaction or memory recall of the intubation procedure. Four of the included studies used similar methods to evaluate these parameters, and the meta-analysis showed that DEX has a stronger amnestic effect and is associated with a lower postoperative recall of endoscopy than REM. Johnston et al reported that the use of REM as the sole sedative agent was associated with a 50% to 100% incidence of memory recall, even at high doses. [9] While the contents of the memories were not perceived by patients as unpleasant, the authors suggested that issues may arise in patients who are extremely anxious and desire a high degree of amnesia.

Two limitations are acknowledged in the present metaanalysis. First, the dosages of DEX and REM were different in each of the included RCTs; this may be attributed to the lack of consensus regarding the optimal doses of these 2 sedative agents when used for AFOI. This variation in drug dose may have accounted for the high heterogeneity of the analyzed outcomes. Second, a subgroup analysis was not performed due to the small number of included studies.

Current evidence indicates that DEX and REM are both effective and well-tolerated in AFOI. While the efficacy of both sedative agents are equivalent, DEX has an advantage in terms of safety.

All authors contributed equally to the manuscript and read and approved the final version of the manuscript. 

Practice guidelines for management of the difficult airway: an updated report by the American Society of Anesthesiologists Task Force on management of the difficult airway

Difficult intubation and extubation in adult anaesthesia

Evaluation of effectiveness of dexmedetomidine and fentanyl-midazolam combination on sedation and safety during awake fiberoptic intubation: a randomized comparative study

Assessment of intubating conditions in adults after induction with propofol and varying doses of remifentanil

Remifentanil-TCI and propofol-TCI for conscious sedation during fibreoptic intubation in the acromegalic patient

Fiberoptic intubation during remifentanil propofol sedation

airway management guideline 2014: to improve the safety of induction of anesthesia

The safety and efficacy of dexmedetomidineremifentanil in children undergoing flexible bronchoscopy: A retrospective dose-finding trial

Conscious sedation for awake fiberoptic intubation: a review of the literature

A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation

Awake intubation under sedation using target-controlled infusion of dexmedetomidine: five case reports

The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fiberoptic nasal intubation

A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fiberoptic nasotracheal intubation

Comparison of dexmedetomidine and sufentanil for conscious sedation in patients undergoing awake fiberoptic nasotracheal intubation: a prospective, randomized and controlled clinical trial

Dexmedetomidine for the management of awake fiberoptic intubation

Safety and efficacy of dexmedetomidine as a sedative agent for performing awake intubation: a meta-analysis

Dexmedetomidine versus remifentanil sedation during awake fiberoptic nasotracheal intubation: a double-blinded randomized controlled trial

Dexmedetomidine versus remifentanil for sedation during awake fiberoptic intubation

Dexmedetomidine versus remifentanil for sedation during awake intubation using a Shikani optical stylet: a randomized, double-blinded, controlled trial

Comparison between remifentanil and dexmedetomidine for sedation during modified awake fiberoptic intubation

A randomized, double-blind comparison of dexmedetomidine and remifentanil for sedation during awake fiberoptic intubations

Remifentanil vs dexmedetomidine for conscious sedation for awake fiberoptic intubation in oral cancer surgeries

Comparison of haemodynamic and neuroendocrine responses between remifentanil-TCI and dexmedetomidine infusion for conscious sedation during fiberoptic intubation

Comparison of remifentanil versus dexmedetomidine in sedation for awake fiberoptic intubation

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

Chinese Society of Anesthesiology Task Force on Airway Management, Airway Management Chinese Society of Anesthesiology Task Force on. Expert Recommendations for Tracheal Intubation in Critically ill Patients with Noval Coronavirus Disease

A prospective cohort study of awake fiberoptic intubation practice at a tertiary centre

Training course in local anaesthesia of the airway and fibreoptic intubation using course delegates as subjects

Difficult Airway Society guidelines for awake tracheal intubation (ATI) in adults

Remifentanil for general anaesthesia: a systematic review

Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis

A comparison of propofol and remifentanil target-controlled infusions to facilitate fiberoptic nasotracheal intubation

Dexamethasone is superior to dexmedetomidine as a perineural adjunct for supraclavicular brachial plexus block: systematic review and indirect meta-analysis

Alpha-2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery

The impact of dexmedetomidine added to ropivicaine for transversus abdominis plane block on stress response in laparoscopic surgery: a randomized controlled trial

Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate

Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil or alfentanil

Manual versus targetcontrolled infusion remifentanil administration in spontaneously breathing patients

Target controlled infusion for remifentanil in vascular patients improves hemodynamics and decreases remifentanil requirement

Modeling the non-steady state respiratory effects of remifentanil in awake and propofol-sedated healthy volunteers

Dexmedetomidine versus remifentanil for monitored anesthesia care during endobronchial ultrasound-guided transbronchial needle aspiration: a randomized controlled trial

Better Hemodynamic Profile of Laryngeal Mask Airway Insertion Compared to Laryngoscopy and Tracheal Intubation

The effect of different doses of esmolol on hemodynamic, bispectral index and movement response during orotracheal intubation: prospective, randomized, double-blind study

Pharmacodynamic interaction of remifentanil and dexmedetomidine on depth of sedation and tolerance of laryngoscopy

Medicine (2021) 100:14 www.md-journal